BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26637502)

  • 1. Hypoxia-inducible factor-1α, adrenomedullin and Bcl-2 although expected are not related to increased uptake of fluorine-18-fluorodeoxyglucose in endometrial cancer.
    Cerci SS; Yalcin Y; Bozkurt KK; Erdemoglu E; Tatar B; Erdemoglu E
    Hell J Nucl Med; 2015; 18(3):228-32. PubMed ID: 26637502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
    Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of hypoxia inducible transcription factor in breast cancer and SUVmax of F-18 FDG PET/CT.
    Jeong YJ; Jung JW; Cho YY; Park SH; Oh HK; Kang S
    Nucl Med Rev Cent East Eur; 2017; 20(1):32-38. PubMed ID: 28198519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between expression of biological markers and [F]fluorodeoxyglucose uptake in endometrial cancer.
    Jo MS; Choi OH; Suh DS; Yun MS; Kim SJ; Kim GH; Jeon HN
    Oncol Res Treat; 2014; 37(1-2):30-4. PubMed ID: 24613906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of prognostic biomarkers (Ki-67, Bcl-2, HIF-1α, cyclin D1) with metabolic tumor volume measured by F-FDG PET/CT inlaryngeal cancer.
    Eryilmaz A; Cengiz A; Basal Y; Meteoglu I; Omurlu IK; Yurekli Y
    J Cancer Res Ther; 2018; 14(5):994-998. PubMed ID: 30197337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
    Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
    Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of immunohistochemical adrenomedullin and Bcl-2 expression in development of type-1 endometrial adenocarcinoma: Adrenomedullin expression in endometrium.
    Bozkurt KK; Yalçın Y; Erdemoğlu E; Tatar B; Erdemoğlu E; Çerçi SS; Çiriş İM; Başpınar Ş; Uğuz A; Kapucuoğlu N
    Pathol Res Pract; 2016 May; 212(5):450-5. PubMed ID: 26972419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of (18)F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with (18)F-FDG PET.
    Norikane T; Yamamoto Y; Maeda Y; Kudomi N; Matsunaga T; Haba R; Iwasaki A; Hoshikawa H; Nishiyama Y
    Nucl Med Commun; 2014 Jan; 35(1):30-5. PubMed ID: 24121312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical overexpression of hypoxia-induced factor 1α associated with slow reduction in
    Chen SW; Lin YC; Chen RY; Hsieh TC; Yen KY; Liang JA; Yang SN; Wang YC; Chen YH; Chow NH; Kao CH
    Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2343-2352. PubMed ID: 27311919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation.
    Lee J; Kim JO; Jung CK; Kim YS; Yoo IeR; Choi WH; Jeon EK; Hong SH; Chun SH; Kim SJ; Kim YK; Kang JH
    Clin Lung Cancer; 2014 Mar; 15(2):e13-21. PubMed ID: 24368212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between hypoxia induced factor-1α and
    Hasbek Z; Ozer H; Erturk SA; Erdiş E; Yucel B; Çiftçi E; Çakmakcilar A
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(6):355-361. PubMed ID: 31672495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between ¹⁸F-FDG uptake and the expression of glucose transporter-1 and hypoxia-inducible factor-1α in transplanted VX2 tumors.
    Xu H; Li B; Yu W; Wang H; Zhao X; Yao Y; Huang D
    Nucl Med Commun; 2013 Oct; 34(10):953-8. PubMed ID: 23887273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer.
    Lee HJ; Ahn BC; Hong CM; Song BI; Kim HW; Kang S; Jeong SY; Lee SW; Lee J
    Nuklearmedizin; 2011; 50(5):204-13. PubMed ID: 21727990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer.
    Nakamura K; Kodama J; Okumura Y; Hongo A; Kanazawa S; Hiramatsu Y
    Int J Gynecol Cancer; 2010 Jan; 20(1):110-5. PubMed ID: 20130510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer.
    Han MW; Lee HJ; Cho KJ; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
    Head Neck; 2012 Oct; 34(10):1395-402. PubMed ID: 22052623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT.
    Crivellaro C; Signorelli M; Guerra L; De Ponti E; Pirovano C; Fruscio R; Elisei F; Montanelli L; Buda A; Messa C
    Gynecol Oncol; 2013 Aug; 130(2):306-11. PubMed ID: 23707673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the association between HIF-1α and HER-2 expression, hormone receptor status, Ki-67 expression, histology and tumor FDG uptake in breast cancer.
    Cerci SM; Bozkurt KK; Eroglu HE; Cerci C; Erdemoglu E; Bulbul PT; Cetin M; Cetin R; Ciris IM; Bulbul M
    Oncol Lett; 2016 Nov; 12(5):3889-3895. PubMed ID: 27895745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of 18F-FDG accumulation in colorectal cancer cells with mutated KRAS.
    Iwamoto M; Kawada K; Nakamoto Y; Itatani Y; Inamoto S; Toda K; Kimura H; Sasazuki T; Shirasawa S; Okuyama H; Inoue M; Hasegawa S; Togashi K; Sakai Y
    J Nucl Med; 2014 Dec; 55(12):2038-44. PubMed ID: 25453050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinoma.
    Sato J; Kitagawa Y; Yamazaki Y; Hata H; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N
    J Nucl Med; 2013 Jul; 54(7):1060-5. PubMed ID: 23699668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.